Insulin Detemir: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Insulin Detemir. Educational only — not medical advice.

Labeled uses

LEVEMIR is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. Limitations of Use LEVEMIR is not recommended for the treatment of diabetic ketoacidosis.

Source: FDA labeling via NIH DailyMed (set 82192527…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.